PE-Backed Biotech OptiNose Raises $120M In Upsized IPO
By Joyce Hanson ( October 13, 2017, 4:16 PM EDT) -- Private equity-backed medical device company OptiNose Inc. raised $120 million in an upsized initial public offering of 7.5 million shares that priced at $16 per share late Thursday and began trading Friday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.